Literature DB >> 35999357

Regulation of tumor metabolism by post translational modifications on metabolic enzymes.

Abhisha Sawant Dessai1, Poonam Kalhotra1, Aaron T Novickis1, Subhamoy Dasgupta2.   

Abstract

Metabolic reprogramming is a hallmark of cancer development, progression, and metastasis. Several metabolic pathways such as glycolysis, tricarboxylic acid (TCA) cycle, lipid metabolism, and glutamine catabolism are frequently altered to support cancer growth. Importantly, the activity of the rate-limiting metabolic enzymes in these pathways are specifically modulated in cancer cells. This is achieved by transcriptional, translational, and post translational regulations that enhance the expression, activity, stability, and substrate sensitivity of the rate-limiting enzymes. These mechanisms allow the enzymes to retain increased activity supporting the metabolic needs of rapidly growing tumors, sustain their survival in the hostile tumor microenvironments and in the metastatic lesions. In this review, we primarily focused on the post translational modifications of the rate-limiting enzymes in the glucose and glutamine metabolism, TCA cycle, and fatty acid metabolism promoting tumor progression and metastasis.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 35999357     DOI: 10.1038/s41417-022-00521-x

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.854


  184 in total

Review 1.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

2.  Cellular stress responses: cell survival and cell death.

Authors:  Simone Fulda; Adrienne M Gorman; Osamu Hori; Afshin Samali
Journal:  Int J Cell Biol       Date:  2010-02-21

Review 3.  Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis.

Authors:  Malachi A Blundon; Subhamoy Dasgupta
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

4.  CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.

Authors:  John Stagg; Upulie Divisekera; Helene Duret; Tim Sparwasser; Michele W L Teng; Phillip K Darcy; Mark J Smyth
Journal:  Cancer Res       Date:  2011-02-03       Impact factor: 12.701

5.  Intrinsic versus Extrinsic Cancer Risks: The Debate Continues.

Authors:  Frédéric Thomas; Benjamin Roche; Beata Ujvari
Journal:  Trends Cancer       Date:  2016-02-10

Review 6.  Metabolic Signaling to the Nucleus in Cancer.

Authors:  Sydney L Campbell; Kathryn E Wellen
Journal:  Mol Cell       Date:  2018-08-02       Impact factor: 17.970

Review 7.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

Review 8.  The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma.

Authors:  Chiara Mazziotta; Carmen Lanzillotti; Roberta Gafà; Antoine Touzé; Marie-Alice Durand; Fernanda Martini; John Charles Rotondo
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

Review 9.  Protein lysine crotonylation: past, present, perspective.

Authors:  Gaoyue Jiang; Chunxia Li; Meng Lu; Kefeng Lu; Huihui Li
Journal:  Cell Death Dis       Date:  2021-07-14       Impact factor: 8.469

Review 10.  Compartmentalised acyl-CoA metabolism and roles in chromatin regulation.

Authors:  Sophie Trefely; Claudia D Lovell; Nathaniel W Snyder; Kathryn E Wellen
Journal:  Mol Metab       Date:  2020-02-14       Impact factor: 7.422

View more
  1 in total

1.  Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer.

Authors:  Ting Dai; Xin Zhang; Xiang Zhou; Xiaoxia Hu; Xiaodi Huang; Feiyue Xing; Han Tian; Yun Li
Journal:  Clin Transl Med       Date:  2022-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.